PNC Financial Services Group’s Voyager Therapeutics VYGR Stock Holding History

PNC Financial Services Group’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$992	Sell	283 -299	-51%	-$1.13K	﹤0.01%	4840
2026 Q1	$2.25K	Sell	582 -238	-29%	-$937	﹤0.01%	4544
2025 Q4	$3.22K	Sell	820 -632	-44%	-$2.79K	﹤0.01%	4394
2025 Q3	$6.78K	Buy	1,452 +884	+156%	+$3.2K	﹤0.01%	4092
2025 Q2	$1.77K	Buy	+568	New	+$1.83K	﹤0.01%	4447
2025 Q1	–	Sell	-30	Closed	-$170	–	5012
2024 Q4	$170	Hold	30	–	–	﹤0.01%	4662
2024 Q3	$176	Hold	30	–	–	﹤0.01%	4691
2024 Q2	$237	Buy	+30	New	+$251	﹤0.01%	4641
2023 Q3	–	Sell	-1,100	Closed	-$12.6K	–	4774
2023 Q2	$12.6K	Buy	+1,100	New	+$11.4K	﹤0.01%	3772
2019 Q3	–	Sell	-99,735	Closed	-$2.71M	–	4120
2019 Q2	$2.71M	Buy	+99,735	New	+$2.28M	﹤0.01%	901

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PNC Financial Services Group's VYGR Position: Q2 2026 in Review

PNC Financial Services Group reduced its Voyager Therapeutics (VYGR) stake by 51% in Q2 2026, selling an estimated $1.13K and leaving 283 shares worth $992. The position accounts for ﹤0.01% of the portfolio, ranked #4840.

PNC Financial Services Group first reported a position in VYGR in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.71M in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

PNC Financial Services Group held 283 shares of Voyager Therapeutics worth $992 as of Q2 2026.
PNC Financial Services Group sold 299 Voyager Therapeutics shares in Q2 2026, an estimated $1.13K.
Voyager Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4840 holding.
PNC Financial Services Group first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 10 quarters since.
PNC Financial Services Group's Voyager Therapeutics position peaked at $2.71M in Q2 2019.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.